Share via:
On a sequential basis, the company’s profit grew 25% from INR 38.3 Cr
The company’s operating revenue stood at INR 216.5 Cr during Q2 FY26, up 22% YoY and 12% QoQ
Its total expenses rose 10% YoY and 7% QoQ to INR 157.3 Cr
PharmEasy
-Owned diagnostics laboratories chain Thyrocare’s net profit surged 81% to INR 47.8 Cr in Q2 FY26 from INR 26.4 Cr in the year-ago quarter. On a sequential basis, the company’s profit grew 25% from INR 38.3 Cr.
The sharp rise in profit…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
On a sequential basis, the company’s profit grew 25% from INR 38.3 Cr
The company’s operating revenue stood at INR 216.5 Cr during Q2 FY26, up 22% YoY and 12% QoQ
Its total expenses rose 10% YoY and 7% QoQ to INR 157.3 Cr
PharmEasy-Owned diagnostics laboratories chain Thyrocare’s net profit surged 81% to INR 47.8 Cr in Q2 FY26 from INR 26.4 Cr in the year-ago quarter. On a sequential basis, the company’s profit grew 25% from INR 38.3 Cr.
The sharp rise in profit…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi
